Atai Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	45.03	190.61	362.27	97.25	30.06
Short-Term Investments	134.73	82.5	0.91	0.23	8.24
Cash & Cash Equivalents	179.76	273.11	363.18	97.47	38.31
Cash Growth	-34.18%	-24.80%	272.60%	154.46%	-
Other Current Assets	5.83	14.04	11.9	2.08	0.84
Total Current Assets	185.59	287.15	375.08	99.55	39.15
Property, Plant & Equipment	2.2	1.15	0.15	0.07	0.02
Long-Term Investments	102.96	14.02	31.59	10.02	22.95
Other Long-Term Assets	2.72	3.13	7.34	1.91	0
Total Long-Term Assets	107.89	18.3	39.08	12	22.97
Total Assets	293.48	305.44	414.17	111.55	62.12
Accounts Payable	4.59	2.4	6	3.08	0.69
Current Debt	0.28	0.18	0	0	0
Other Current Liabilities	15.26	17.32	14.93	9.22	0.92
Total Current Liabilities	20.12	19.9	20.94	12.3	1.61
Long-Term Debt	18.87	15.16	0.74	2.18	0.16
Other Long-Term Liabilities	10.18	4.62	6.53	1.71	0.57
Total Long-Term Liabilities	29.04	19.78	7.27	3.88	0.73
Total Liabilities	49.16	39.68	28.21	16.18	2.34
Total Debt	19.14	15.34	0.74	2.18	0.16
Debt Growth	24.78%	1964.74%	-65.87%	1286.62%	-
Retained Earnings	-550.94	-510.19	-357.8	-190	-20.15
Comprehensive Income	-19.46	-21.7	-8.34	5.82	-1.43
Shareholders' Equity	242.96	260.74	376.91	90.82	58.75
Net Cash / Debt	160.62	257.77	362.44	95.3	38.15
Net Cash / Debt Growth	-37.69%	-28.88%	280.33%	149.80%	-
Net Cash Per Share	1.01	1.66	2.62	1.02	0.44
Working Capital	165.47	267.25	354.15	87.25	37.54
Book Value Per Share	1.53	1.67	2.73	0.98	0.68

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).